Towards Healthcare
DNA Methylation Market to Grow at 13.64% till 2035

DNA Methylation Market 2026 Expands with Oncology Demand

Based on market forecasts, the DNA methylation sector will expand from USD 2.05 billion in 2025 to USD 7.36 billion by 2035, experiencing a CAGR of 13.64%. The emerging trend of genomic imprinting and gene expression regulation drives the importance of DNA methylation. North America dominated the market in 2024 owing to the robust research and development infrastructure and the growing demand for personalized medicine.

Content

  • Last Updated: 14 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The DNA methylation market stands at USD 2.05 billion in 2025 and is expected to reach USD 7.36 billion by 2035, growing at a CAGR of 13.64% from 2024 to 2034.

North America is currently leading the DNA methylation market, driven by a strong research and development environment and advancements in cutting-edge technologies.

The key players in the DNA methylation market include Bio-Rad Laboratories, Thermo Fisher Scientific Inc., QIAGEN N.V., Illumina, Inc. Agilent Technologies.

USDA, the Government of Canada, the U.S Economic Research Service, ITIF

The DNA methylation market includes technologies, assays, reagents, sequencing platforms, bioinformatics tools, and clinical tests used to detect and analyze methylation patterns for applications in research, diagnostics, and personalized medicine.

Technological advancements like next-generation sequencing, nanopore sequencing, and AI-driven data analysis are propelling the DNA methylation market forward.
Any Questions